Article

The Persistence of Neutralising Antibodies up to 11 months after SARS-CoV-2 Infection in the Southern Region of New Zealand

2021-10-27

Abstract excerpt

<h4>Summary</h4> During the first wave of SARS-CoV-2 infection in New Zealand a cohort of 78 PCR-confirmed COVID-19 cases was recruited in the Southern District Health Board region. Here we report on this unique cohort nearly 1-year after infection. There was no known community transmission in the region over the study period due to New Zealand’s elimination status at the time, nor had any participants received a...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 1736f2aa-060a-5cac-b436-59c3d4e698f9
DOI: 10.1101/2021.10.26.21265501

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

The Persistence of Neutralising Antibodies up to 11 months after SARS-CoV-2 Infection in the Southern Region of New ZealandDOI 10.1101/2021.10.26.21265501Read

Neutralising antibodies predict protection from severe COVID-19Semantic proximity Read

Breadth of neutralising antibody responses to SARS-CoV-2 variants of concern is augmented by vaccination following prior infection: studies in UK healthcare workers and immunodeficient patientsSemantic proximity Read

Characterising heterogeneity and sero-reversion in antibody responses to mild SARS⍰CoV-2 infection: a cohort study using time series analysis and mechanistic modellingSemantic proximity Read

Lineage-specific neutralising antibodies after SARS-CoV-2 mild disease. Immune boosting effect of vaccinationSemantic proximity Read

Antibody Persistence in the Six Months Following SARS-CoV-2 Infection Among Hospital WorkersSemantic proximity Read

Antibody response to SARS-CoV-2 infection in humans: a systematic reviewSemantic proximity Read

SARS-CoV-2 infection in fully vaccinated individuals of old age strongly boosters the humoral immune responseSemantic proximity Read

Nucleocapsid and spike antibody responses post virologically confirmed SARS-CoV-2 infection: An observational analysis in the Virus Watch community cohortSemantic proximity Read

'One Year Later' - SARS-CoV-2-Specific Immunity in Mild Cases of COVID-19Semantic proximity Read

The Impact of SARS-CoV-2 Vaccination and Infection on Neutralising Antibodies: A Nation-Wide Cross-Sectional AnalysisSemantic proximity Read

Persistence of immunity and impact of a third (booster) dose of an inactivated SARS-CoV-2 vaccine, BBV152; a phase 2, double-blind, randomised controlled trialSemantic proximity Read

Immunogenicity of BNT162b2 COVID-19 vaccine in New Zealand adultsSemantic proximity Read